Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome.
Qing-Bing ZhouZheng-Tang LiuHong-Zhi WangXiao-Qing GuoYong-Gang XuXiao-Mei HuPublished in: Drug design, development and therapy (2020)
These data show a potential clinical application of As2S2 as an innovative hypermethylation agent in MDS.